Cell-specific regulation of androgen receptor phosphorylation in vivo

Samir S. Taneja, Susan Ha, Nicole K. Swenson, Hong Ying Huang, Peng Lee, Jonathan Melamed, Ellen Shapiro, Michael J. Garabedian, Susan K. Logan

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

The biological ramifications of phosphorylation of the androgen receptor (AR) are largely unknown. To examine the phosphorylation of AR at serine 213, a putative substrate for Akt, a phosphorylation site-specific antibody was generated. The use of this antibody indicated that AR Ser-213 is phosphorylated in vivo and that phosphorylation is tightly regulated in a cell type-specific manner. Furthermore, Ser-213 phosphorylation took place with rapid kinetics and was inhibited by the phosphatidylinositol 3-kinase inhibitor LY294002. Phosphorylation occurred in response to R1881 and dihydrotestosterone but weakly if at all in response to testosterone. It did not occur in response to AR antagonists or growth factor stimulation in the absence of an AR agonist. Transcription assays using an AR-responsive reporter gene construct showed that activated phosphatidylinositol 3-kinase inhibited transcription mediated by wild type AR but not that of a mutant AR variant (S213A), which could not be phosphorylated at Ser-213. By immunohistochemistry, the AR Ser(P)-213 antigen was detected in prostate epithelial but not stromal cells despite the fact that an antibody recognizing both phosphorylated and non-phosphorylated forms of AR demonstrates that AR is present in both cell types as expected. In fetal tissue the AR-Ser(P)-213 antigen was present in epithelial cells of the urogenital sinus when endogenous androgen levels were high and activated Akt was prevalent, but absent at a later stage of development when endogenous androgen levels were low and Akt activation was minimal. Immunoreactivity was evident in differentiated cells lining the lumen of the urogenital sinus but not in rapidly dividing, Ki67 positive cells within the developing prostate or stromal tissue, suggesting that site-specific phosphorylation of AR Ser-213 by cellular kinases occurs in a non-proliferating cellular milieu.

Original languageEnglish (US)
Pages (from-to)40916-40924
Number of pages9
JournalJournal of Biological Chemistry
Volume280
Issue number49
DOIs
StatePublished - Dec 9 2005
Externally publishedYes

Fingerprint

Phosphorylation
Androgen Receptors
Phosphatidylinositol 3-Kinase
Androgens
Transcription
Antibodies
Prostate
Androgen Receptor Antagonists
Metribolone
Tissue
Antigens
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Dihydrotestosterone
Stromal Cells
Linings
Reporter Genes
Serine
Testosterone
Assays
Intercellular Signaling Peptides and Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Taneja, S. S., Ha, S., Swenson, N. K., Huang, H. Y., Lee, P., Melamed, J., ... Logan, S. K. (2005). Cell-specific regulation of androgen receptor phosphorylation in vivo. Journal of Biological Chemistry, 280(49), 40916-40924. https://doi.org/10.1074/jbc.M508442200

Cell-specific regulation of androgen receptor phosphorylation in vivo. / Taneja, Samir S.; Ha, Susan; Swenson, Nicole K.; Huang, Hong Ying; Lee, Peng; Melamed, Jonathan; Shapiro, Ellen; Garabedian, Michael J.; Logan, Susan K.

In: Journal of Biological Chemistry, Vol. 280, No. 49, 09.12.2005, p. 40916-40924.

Research output: Contribution to journalArticle

Taneja, SS, Ha, S, Swenson, NK, Huang, HY, Lee, P, Melamed, J, Shapiro, E, Garabedian, MJ & Logan, SK 2005, 'Cell-specific regulation of androgen receptor phosphorylation in vivo', Journal of Biological Chemistry, vol. 280, no. 49, pp. 40916-40924. https://doi.org/10.1074/jbc.M508442200
Taneja SS, Ha S, Swenson NK, Huang HY, Lee P, Melamed J et al. Cell-specific regulation of androgen receptor phosphorylation in vivo. Journal of Biological Chemistry. 2005 Dec 9;280(49):40916-40924. https://doi.org/10.1074/jbc.M508442200
Taneja, Samir S. ; Ha, Susan ; Swenson, Nicole K. ; Huang, Hong Ying ; Lee, Peng ; Melamed, Jonathan ; Shapiro, Ellen ; Garabedian, Michael J. ; Logan, Susan K. / Cell-specific regulation of androgen receptor phosphorylation in vivo. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 49. pp. 40916-40924.
@article{61bb7ba72bc64de4bce6ba19f4d51496,
title = "Cell-specific regulation of androgen receptor phosphorylation in vivo",
abstract = "The biological ramifications of phosphorylation of the androgen receptor (AR) are largely unknown. To examine the phosphorylation of AR at serine 213, a putative substrate for Akt, a phosphorylation site-specific antibody was generated. The use of this antibody indicated that AR Ser-213 is phosphorylated in vivo and that phosphorylation is tightly regulated in a cell type-specific manner. Furthermore, Ser-213 phosphorylation took place with rapid kinetics and was inhibited by the phosphatidylinositol 3-kinase inhibitor LY294002. Phosphorylation occurred in response to R1881 and dihydrotestosterone but weakly if at all in response to testosterone. It did not occur in response to AR antagonists or growth factor stimulation in the absence of an AR agonist. Transcription assays using an AR-responsive reporter gene construct showed that activated phosphatidylinositol 3-kinase inhibited transcription mediated by wild type AR but not that of a mutant AR variant (S213A), which could not be phosphorylated at Ser-213. By immunohistochemistry, the AR Ser(P)-213 antigen was detected in prostate epithelial but not stromal cells despite the fact that an antibody recognizing both phosphorylated and non-phosphorylated forms of AR demonstrates that AR is present in both cell types as expected. In fetal tissue the AR-Ser(P)-213 antigen was present in epithelial cells of the urogenital sinus when endogenous androgen levels were high and activated Akt was prevalent, but absent at a later stage of development when endogenous androgen levels were low and Akt activation was minimal. Immunoreactivity was evident in differentiated cells lining the lumen of the urogenital sinus but not in rapidly dividing, Ki67 positive cells within the developing prostate or stromal tissue, suggesting that site-specific phosphorylation of AR Ser-213 by cellular kinases occurs in a non-proliferating cellular milieu.",
author = "Taneja, {Samir S.} and Susan Ha and Swenson, {Nicole K.} and Huang, {Hong Ying} and Peng Lee and Jonathan Melamed and Ellen Shapiro and Garabedian, {Michael J.} and Logan, {Susan K.}",
year = "2005",
month = "12",
day = "9",
doi = "10.1074/jbc.M508442200",
language = "English (US)",
volume = "280",
pages = "40916--40924",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "49",

}

TY - JOUR

T1 - Cell-specific regulation of androgen receptor phosphorylation in vivo

AU - Taneja, Samir S.

AU - Ha, Susan

AU - Swenson, Nicole K.

AU - Huang, Hong Ying

AU - Lee, Peng

AU - Melamed, Jonathan

AU - Shapiro, Ellen

AU - Garabedian, Michael J.

AU - Logan, Susan K.

PY - 2005/12/9

Y1 - 2005/12/9

N2 - The biological ramifications of phosphorylation of the androgen receptor (AR) are largely unknown. To examine the phosphorylation of AR at serine 213, a putative substrate for Akt, a phosphorylation site-specific antibody was generated. The use of this antibody indicated that AR Ser-213 is phosphorylated in vivo and that phosphorylation is tightly regulated in a cell type-specific manner. Furthermore, Ser-213 phosphorylation took place with rapid kinetics and was inhibited by the phosphatidylinositol 3-kinase inhibitor LY294002. Phosphorylation occurred in response to R1881 and dihydrotestosterone but weakly if at all in response to testosterone. It did not occur in response to AR antagonists or growth factor stimulation in the absence of an AR agonist. Transcription assays using an AR-responsive reporter gene construct showed that activated phosphatidylinositol 3-kinase inhibited transcription mediated by wild type AR but not that of a mutant AR variant (S213A), which could not be phosphorylated at Ser-213. By immunohistochemistry, the AR Ser(P)-213 antigen was detected in prostate epithelial but not stromal cells despite the fact that an antibody recognizing both phosphorylated and non-phosphorylated forms of AR demonstrates that AR is present in both cell types as expected. In fetal tissue the AR-Ser(P)-213 antigen was present in epithelial cells of the urogenital sinus when endogenous androgen levels were high and activated Akt was prevalent, but absent at a later stage of development when endogenous androgen levels were low and Akt activation was minimal. Immunoreactivity was evident in differentiated cells lining the lumen of the urogenital sinus but not in rapidly dividing, Ki67 positive cells within the developing prostate or stromal tissue, suggesting that site-specific phosphorylation of AR Ser-213 by cellular kinases occurs in a non-proliferating cellular milieu.

AB - The biological ramifications of phosphorylation of the androgen receptor (AR) are largely unknown. To examine the phosphorylation of AR at serine 213, a putative substrate for Akt, a phosphorylation site-specific antibody was generated. The use of this antibody indicated that AR Ser-213 is phosphorylated in vivo and that phosphorylation is tightly regulated in a cell type-specific manner. Furthermore, Ser-213 phosphorylation took place with rapid kinetics and was inhibited by the phosphatidylinositol 3-kinase inhibitor LY294002. Phosphorylation occurred in response to R1881 and dihydrotestosterone but weakly if at all in response to testosterone. It did not occur in response to AR antagonists or growth factor stimulation in the absence of an AR agonist. Transcription assays using an AR-responsive reporter gene construct showed that activated phosphatidylinositol 3-kinase inhibited transcription mediated by wild type AR but not that of a mutant AR variant (S213A), which could not be phosphorylated at Ser-213. By immunohistochemistry, the AR Ser(P)-213 antigen was detected in prostate epithelial but not stromal cells despite the fact that an antibody recognizing both phosphorylated and non-phosphorylated forms of AR demonstrates that AR is present in both cell types as expected. In fetal tissue the AR-Ser(P)-213 antigen was present in epithelial cells of the urogenital sinus when endogenous androgen levels were high and activated Akt was prevalent, but absent at a later stage of development when endogenous androgen levels were low and Akt activation was minimal. Immunoreactivity was evident in differentiated cells lining the lumen of the urogenital sinus but not in rapidly dividing, Ki67 positive cells within the developing prostate or stromal tissue, suggesting that site-specific phosphorylation of AR Ser-213 by cellular kinases occurs in a non-proliferating cellular milieu.

UR - http://www.scopus.com/inward/record.url?scp=28844467498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28844467498&partnerID=8YFLogxK

U2 - 10.1074/jbc.M508442200

DO - 10.1074/jbc.M508442200

M3 - Article

C2 - 16210317

AN - SCOPUS:28844467498

VL - 280

SP - 40916

EP - 40924

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 49

ER -